Regulatory Strategy, Qualification & Classification
Correct qualification and classification determine the conformity assessment route, Notified Body involvement, evidence burden, QMS expectations and post-market obligations. NKB Regovanta establishes the regulatory basis before technical documentation is developed.
For MDR Medical Devices
For IVDR In Vitro Diagnostics
Classification Drives the Entire Evidence Roadmap
We do not stop at “what class is the product?” We ask what the classification means for evidence, clinical studies, QMS scope, Notified Body scrutiny, timelines and lifecycle obligations — and build the roadmap from that decision.
Conformity Route Matrix
MDR Annex IX / X / XI
QMS assessment, technical documentation assessment & product verification routes.
IVDR Annex IX / X / XI
Over 85% of IVDs now require Notified Body certification under Rules 1–7.
Need Classification Strategy?
Establish defensible MDR & IVDR classification rules before investing in dossier compilation.
Define PathwayEstablish Your EU Regulatory Identity with Absolute Certainty
Partner with our senior regulatory strategists to classify your device and select the optimal conformity assessment route.
